Most patients with bowel cancer not advised to exercise despite its health benefits
the ONA take:
Many patients with bowel cancer say they were not advised to exercise regularly after diagnosis. Exercise can help ease fatigue, depression, and anxiety; is linked to better survival and better quality of life for patients; and reduces the risk of recurrence.
However, a Cancer Research UK study has shown that many patients are not advised to be more active.
The researchers asked more than 15,000 patients with bowel cancer about their current level of exercise and whether they were advised to be more active.
Only 31% said they were advised to exercise at any point during their treatment, 69% said they were not advised at all.
Current NHS guidelines recommend that healthy people get at least 2.5 hours of moderate physical activity per week.
Although no guidelines specific to patients with bowel cancer are in place, the researchers recommend that patients discuss exercise with their doctor and get advice on what is safe for them and suits their lifestyle and ability.
Many patients with bowel cancer say they were not advised to exercise regularly after diagnosis.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Medication, Vaccination Uptake Improved by Involving Pharmacists in Elder Cancer Care
- Molecular Features May Predict Response in Primary Pancreatic Cancer
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Commission Seeks Standardized Adverse Event Assessments in Hematologic Malignancies
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Clinical Characteristics That Increase Risk of Chemotherapy-Induced Febrile Neutropenia Identified
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Counseling Patients on Oral Chemotherapy
- Patients and Caregivers Worry About Cost of Cancer Care
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|